Regulome‐wide association study identifies genetically driven accessible regions associated with pancreatic cancer risk
International Journal of Cancer · 2024
DOI: 10.1002/ijc.34761 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, 2024. Verfasst von Shuai Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Epidemiology Division, Population Sciences in the Pacific Program, University of Hawaii Cancer Center, University of Hawaii at Manoa, Honolulu…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCI NIH HHS, NHGRI NIH HHS.
Abstract (Originalsprache)
Genome‐wide association studies (GWAS) have identified two dozen genetic variants that are associated with the risk of pancreatic ductal adenocarcinoma (PDAC), a deadly malignancy. However, a majority of these variants are located in noncoding regions of the genome, which limits the translation of GWAS findings into clinical applications. The regulome‐wide association study (RWAS) is a recently developed method for identifying TF binding‐induced accessibility regions for diseases. However, their potential connection to PDAC has yet to be fully explored. We evaluated the associations between genetically predicted levels of chromatin accessibility and risk of PDAC by using pan‐cancer chromatin accessibility genetic prediction models. Our analysis included 8275 cases and 6723 controls from the PanScan (I, II, and III) and PanC4 consortia. To further refine our results, we also integrated genes associated to allele‐specific accessibility quantitative trait loci (as‐aQTL) and TF motifs located in the as‐aQTL. We found that 50 chromatin accessibility features were associated with PDAC risk at a false discovery rate (FDR) of less than 0.05. A total of 28 RWAS peaks were identified as conditionally significant. By integrating the results from as‐aQTL, motif analysis, and RWAS, we identified candidate causal regulatory elements for two potential chromatin accessibility regions (THCA_89956 and ESCA_89167) that are associated with PDAC risk. Our study identified chromatin accessibility features in noncoding genomic regions that are associated with PDAC risk. We also predicted the associated genes and disrupt motifs. Our findings provide new insights into the regulatory mechanisms of noncoding regions for pancreatic tumorigenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Epidemiology Division, Population Sciences in the Pacific Program, University of Hawaii Cancer Center, University of Hawaii at Manoa, Honolulu, Hawaii, USA.
- Division of Cancer Research and Training, Department of Internal Medicine, Charles Drew University of Medicine and Science, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
- Department of Quantitative Health Sciences, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, Hawaii, USA.
ORCID-Profile: Jingjing Zhu, Youping Deng, Lang Wu
Förderung
- NHLBI NIH HHS
- NCI NIH HHS
- NHGRI NIH HHS
- NIDDK NIH HHS
- CCR NIH HHS
- NIGMS NIH HHS
- National Human Genome Research Institute
- National Institute of General Medical Sciences
Zitieren
APA
Liu, S., Zhong, H., Zhu, J., Wu, Y., Deng, Y., & Wu, L. (2024). Regulome‐wide association study identifies genetically driven accessible regions associated with pancreatic cancer risk. International Journal of Cancer. https://doi.org/10.1002/ijc.34761
Vancouver
Liu S, Zhong H, Zhu J, Wu Y, Deng Y, Wu L. Regulome‐wide association study identifies genetically driven accessible regions associated with pancreatic cancer risk. International Journal of Cancer. 2024. doi:10.1002/ijc.34761
BibTeX
@article{Liu2024,
author = {Liu, Shuai and Zhong, Hua and Zhu, Jingjing and Wu, Yong and Deng, Youping and Wu, Lang},
title = {Regulome‐wide association study identifies genetically driven accessible regions associated with pancreatic cancer risk},
journal = {International Journal of Cancer},
year = {2024},
doi = {10.1002/ijc.34761}
}
EUVIMED